GVB-positive neurons are resilient to tau-induced impairment of protein synthesis
Jasper Franciscus Maria SmitsiD, Thijmen W. LigthartiD, Marta Jorge‐OlivaiD, Skip Middelhoff, Fleur Schipper, Débora Pita-IllobreiD, Ka Wan LiiD, Wiep ScheperiD
Abstract
In Alzheimers disease, many surviving neurons with tau pathology contain granulovacuolar degeneration bodies (GVBs), neuron-specific lysosomal structures induced by pathological tau assemblies. This could indicate a neuroprotective role for GVBs, however, the mechanism of GVB formation and its functional implications are elusive. Here, we demonstrate that CK1{delta} activity is required for GVB formation. CK1{delta} is sequestered in the GVB during this process in an autophagy-dependent manner. We show that neurons with GVBs (GVB+) are resilient to tau-induced impairment of global protein synthesis and are protected against tau-mediated neurodegeneration. GVB+ neurons do not exhibit differential activation of proteostatic stress responses, but have increased ribosomal content. Importantly, unlike neurons without GVBs, GVB+ neurons fully retain the capacity to induce long-term potentiation-induced protein synthesis in the presence of tau pathology. Our results have identified CK1{delta} as a key regulator of GVB formation that confers a protective neuron-specific proteostatic stress response to tau pathology. These findings provide novel opportunities for targeting neuronal resilience in tauopathies. HighlightsO_LIGVB+ neurons are protected against tau-induced neurodegeneration C_LIO_LICK1{delta} activity is essential for the formation of GVBs C_LIO_LIGVB+ neurons are resilient to tau-induced impairment of protein synthesis C_LIO_LIGVB+ neurons retain the capacity for LTP-regulated protein synthesis C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=154 SRC="FIGDIR/small/645932v2_ufig1.gif" ALT="Figure 1"> View larger version (32K): org.highwire.dtl.DTLVardef@cda628org.highwire.dtl.DTLVardef@157bcb8org.highwire.dtl.DTLVardef@126dbe6org.highwire.dtl.DTLVardef@2efe8f_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pathological α-synuclein elicits granulovacuolar degeneration independent of tau
Dylan J. Dues, Madalynn L. Erb, … Darren J. Moore·Translational NeurodegenerationPeer-reviewed·Jun 19, 2025
- Pathological tau activates inflammatory nuclear factor-kappa B (NF-κB) and pT181-Qβ vaccine attenuates NF-κB in PS19 tauopathy mice
Karthikeyan Tangavelou, Shanya Jiang, … Kiran Bhaskar·bioRxiv·Mar 10, 2025
- GPCR-mediated clearance of tau in post-synaptic compartments attenuates tau pathology in vivo
Ari W. Schaler, Avery M. Runyan, … Natura Myeku·bioRxiv·Jan 21, 2020
- Alzheimer's disease brain-derived tau-containing extracellular vesicles: Pathobiology and GABAergic neuronal transmission
Zhi Ruan, Dhruba Pathak, … Tsuneya Ikezu·BrainPeer-reviewed·Oct 7, 2020
- Pharmacological potentiation of Nav1.1 channels in interneurons mitigates tau depositions and neuronal death in a mouse model of neurodegenerative dementias
Kazuaki Sampei, Junya Hirokawa, … Masafumi Shimojo·bioRxiv·Aug 20, 2025
- Endo-lysosomal sorting and degradation of Tau mediates glucocorticoid-driven hippocampalmalfunction
João Vaz‐Silva, Patrícia Gomes, … Clarissa L. Waites·The EMBO JournalPeer-reviewed·Aug 30, 2018